Answers are grounded in this paper and cite their sources.
The fruit extract of Xylocarpus granatum J. Koenig (Meliaceae) is rich in bioactive phytoconstituents with documented pharmacological activities, but its precise role in modulating neurological disorders remains insufficiently understood. The present study was designed to evaluate the anxiolytic-like and sedative potentials of X. granatum fruit extract (XGFE) using established in vivo experimental models. To assess behavioral, locomotor, and exploratory parameters associated with anxiolytic-like activity, Swiss albino mice were divided into experimental groups and treated with diazepam (1 mg/kg), flumazenil (0.1 mg/kg), and XGFE (250 and 500 mg/kg) across four distinct behavioral paradigms (the open-field, hole-cross, swing, and light-dark tests). Sedative activity was subsequently assessed using the thiopental sodium-induced sleeping test to measure sleep latency and duration. Treatment with XGFE (250 and 500 mg/kg) elicited significant (p < 0.05) decreases in locomotor and exploratory measures, thereby indicating an anxiolytic-like calming effect. In addition, XGFE (500 mg/kg) reduced sleep latency to 19.2 min (NC: 30.4 min) and prolonged sleep duration to 147.2 min (NC: 47.2 min), indicating a potential sedative effect in mice. Moreover, co-administration of XGFE alongside diazepam (DZP) at 3 mg/kg prolonged the duration of CNS-depressant activity (177 min). Thus, the present findings indicate that XGFE exhibits anxiolytic-like and sedative effects, suggesting its possible utility as a naturally derived therapeutic candidate for neurological management.
No takes yet. Share an insight, caveat, or question.
Snigdha et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: